Pagé P L, Pelletier L C, Kaltenbrunner W, Vitali E, Roy D, Nadeau R
Department of Surgery, Hôpital Sacré-Coeur de Montréal, Québec, Canada.
J Thorac Cardiovasc Surg. 1990 Jul;100(1):83-7.
From 1983 to 1988, 51 patients with the Wolff-Parkinson-White syndrome underwent surgical ablation of an accessory conduction pathway, 25 by the classic endocardial approach and 26 by the epicardial technique supplemented by cryosurgery. In the endocardial and epicardial groups, the accessory pathway was in the left free wall in 22 and 18 patients, respectively, posterior septal in two and seven, and in the right free wall in one patient in each group. There was no early or late death in the endocardial group, and postoperative complications developed in five patients (20%). Pathway ablation was completely successful in 22 patients (88%), preexcitation recurred in two patients (8%), and one had recurrence of supraventricular tachycardia (4%). One of the failures occurred with a posterior septal pathway (50%), and the two others with a left free-wall pathway (9%). With the epicardial technique, there were no early deaths and one late death caused by atherosclerotic coronary artery disease. Five patients (19%) had postoperative complications. The pathway was ablated successfully in 22 patients (85%), preexcitation recurred in three patients (12%), and supraventricular tachycardia remained inducible in another patient despite disappearance of the delta wave. Three of those failures occurred with anterior left free-wall pathways (16%), but only one patient had recurrent supraventricular tachycardia (4%) requiring immediate reoperation, which was successful. In conclusion, although epicardial or endocardial approaches produced similar results, our observations suggest that left free-wall accessory pathways located high anteriorly may be ablated in a more reproducible way with the endocardial technique, whereas the epicardial approach appears easier for posterior septal pathways. We therefore believe that any surgeon beginning such surgery should be aware of the possibilities and limitations of each of the two techniques.
1983年至1988年期间,51例预激综合征患者接受了附加传导通路的手术消融,其中25例采用经典的心内膜途径,26例采用心外膜技术并辅以冷冻手术。在心内膜组和心外膜组中,附加通路分别位于左游离壁的患者有22例和18例,后间隔的分别有2例和7例,每组各有1例位于右游离壁。心内膜组无早期或晚期死亡病例,5例患者(20%)出现术后并发症。22例患者(88%)的通路消融完全成功,2例患者(8%)预激复发,1例患者(4%)出现室上性心动过速复发。其中1例失败发生在后间隔通路(50%),另外2例发生在左游离壁通路(9%)。采用心外膜技术时,无早期死亡病例,1例晚期死亡由动脉粥样硬化性冠状动脉疾病引起。5例患者(19%)出现术后并发症。22例患者(85%)的通路消融成功,3例患者(12%)预激复发,尽管δ波消失,但另1例患者仍可诱发室上性心动过速。其中3例失败发生在左前游离壁通路(16%),但只有1例患者(4%)出现室上性心动过速复发,需要立即再次手术,手术成功。总之,尽管心外膜或心内膜途径产生的结果相似,但我们的观察表明,位于前高位的左游离壁附加通路采用心内膜技术消融可能更具可重复性,而心外膜途径似乎更适合后间隔通路。因此,我们认为任何开始此类手术的外科医生都应了解这两种技术各自的可能性和局限性。